nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—PTGFR—corpus luteum—breast cancer	0.101	0.519	CbGeAlD
Latanoprost—PTGFR—nipple—breast cancer	0.0129	0.0665	CbGeAlD
Latanoprost—SLCO2B1—mammary gland—breast cancer	0.00859	0.0443	CbGeAlD
Latanoprost—PTGFR—uterus—breast cancer	0.00717	0.037	CbGeAlD
Latanoprost—PTGFR—adipose tissue—breast cancer	0.00701	0.0362	CbGeAlD
Latanoprost—PTGFR—female reproductive system—breast cancer	0.00644	0.0333	CbGeAlD
Latanoprost—PTGFR—adrenal gland—breast cancer	0.00629	0.0325	CbGeAlD
Latanoprost—PTGFR—female gonad—breast cancer	0.00586	0.0303	CbGeAlD
Latanoprost—Iloprost—PTGER1—breast cancer	0.00583	0.28	CrCbGaD
Latanoprost—Bimatoprost—PTGER1—breast cancer	0.00568	0.273	CrCbGaD
Latanoprost—PTGFR—endocrine gland—breast cancer	0.00545	0.0281	CbGeAlD
Latanoprost—SLCO2B1—uterus—breast cancer	0.00395	0.0204	CbGeAlD
Latanoprost—SLCO2B1—adipose tissue—breast cancer	0.00387	0.02	CbGeAlD
Latanoprost—PTGFR—lymph node—breast cancer	0.00377	0.0195	CbGeAlD
Latanoprost—SLC22A1—adipose tissue—breast cancer	0.00369	0.0191	CbGeAlD
Latanoprost—SLCO2B1—female reproductive system—breast cancer	0.00355	0.0183	CbGeAlD
Latanoprost—SLCO2B1—adrenal gland—breast cancer	0.00347	0.0179	CbGeAlD
Latanoprost—Dinoprost Tromethamine—PTGER1—breast cancer	0.00344	0.165	CrCbGaD
Latanoprost—SLCO2B1—female gonad—breast cancer	0.00323	0.0167	CbGeAlD
Latanoprost—SLCO2B1—endocrine gland—breast cancer	0.00301	0.0155	CbGeAlD
Latanoprost—SLC22A1—endocrine gland—breast cancer	0.00287	0.0148	CbGeAlD
Latanoprost—Iloprost—PDE4D—breast cancer	0.0027	0.13	CrCbGaD
Latanoprost—Dinoprost Tromethamine—HPGDS—breast cancer	0.00234	0.112	CrCbGaD
Latanoprost—SLCO2B1—lymph node—breast cancer	0.00208	0.0107	CbGeAlD
Latanoprost—Tafluprost—PTGS2—breast cancer	0.000817	0.0393	CrCbGaD
Latanoprost—Headache—Raloxifene—breast cancer	0.000587	0.00112	CcSEcCtD
Latanoprost—Headache—Idarubicin—breast cancer	0.000587	0.00112	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Capecitabine—breast cancer	0.000585	0.00111	CcSEcCtD
Latanoprost—Erythema—Mitoxantrone—breast cancer	0.000584	0.00111	CcSEcCtD
Latanoprost—Pain—Tamoxifen—breast cancer	0.000578	0.0011	CcSEcCtD
Latanoprost—Arthralgia—Thiotepa—breast cancer	0.000576	0.0011	CcSEcCtD
Latanoprost—Dry eye—Epirubicin—breast cancer	0.000575	0.0011	CcSEcCtD
Latanoprost—Dyspnoea—Goserelin—breast cancer	0.000575	0.0011	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—breast cancer	0.000572	0.00109	CcSEcCtD
Latanoprost—Erythema—Gemcitabine—breast cancer	0.000569	0.00108	CcSEcCtD
Latanoprost—Nervous system disorder—Vinorelbine—breast cancer	0.000567	0.00108	CcSEcCtD
Latanoprost—Pain—Melphalan—breast cancer	0.000566	0.00108	CcSEcCtD
Latanoprost—Back pain—Irinotecan—breast cancer	0.000565	0.00108	CcSEcCtD
Latanoprost—Back pain—Mitoxantrone—breast cancer	0.000565	0.00108	CcSEcCtD
Latanoprost—Angina pectoris—Docetaxel—breast cancer	0.000564	0.00108	CcSEcCtD
Latanoprost—Skin disorder—Vinorelbine—breast cancer	0.000561	0.00107	CcSEcCtD
Latanoprost—Asthma—Capecitabine—breast cancer	0.000561	0.00107	CcSEcCtD
Latanoprost—Erythema—Fluorouracil—breast cancer	0.000559	0.00107	CcSEcCtD
Latanoprost—Pain—Goserelin—breast cancer	0.000552	0.00105	CcSEcCtD
Latanoprost—Vision blurred—Mitoxantrone—breast cancer	0.00055	0.00105	CcSEcCtD
Latanoprost—Back pain—Gemcitabine—breast cancer	0.00055	0.00105	CcSEcCtD
Latanoprost—Angina pectoris—Capecitabine—breast cancer	0.000547	0.00104	CcSEcCtD
Latanoprost—Nervous system disorder—Thiotepa—breast cancer	0.000541	0.00103	CcSEcCtD
Latanoprost—Bronchitis—Capecitabine—breast cancer	0.00054	0.00103	CcSEcCtD
Latanoprost—Connective tissue disorder—Paclitaxel—breast cancer	0.000538	0.00103	CcSEcCtD
Latanoprost—Pruritus—Chlorambucil—breast cancer	0.000537	0.00102	CcSEcCtD
Latanoprost—Skin disorder—Thiotepa—breast cancer	0.000536	0.00102	CcSEcCtD
Latanoprost—Dry eye—Doxorubicin—breast cancer	0.000532	0.00101	CcSEcCtD
Latanoprost—Vision blurred—Fluorouracil—breast cancer	0.000527	0.00101	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Vinorelbine—breast cancer	0.000527	0.001	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Capecitabine—breast cancer	0.000521	0.000994	CcSEcCtD
Latanoprost—Hepatic function abnormal—Epirubicin—breast cancer	0.000517	0.000986	CcSEcCtD
Latanoprost—Dyspnoea—Vinorelbine—breast cancer	0.000515	0.000982	CcSEcCtD
Latanoprost—Eczema—Epirubicin—breast cancer	0.000503	0.000959	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Thiotepa—breast cancer	0.000503	0.000959	CcSEcCtD
Latanoprost—Conjunctivitis—Docetaxel—breast cancer	0.000502	0.000957	CcSEcCtD
Latanoprost—Eye pain—Epirubicin—breast cancer	0.000501	0.000955	CcSEcCtD
Latanoprost—Chest pain—Mitoxantrone—breast cancer	0.000497	0.000948	CcSEcCtD
Latanoprost—Arthralgia—Mitoxantrone—breast cancer	0.000497	0.000948	CcSEcCtD
Latanoprost—Pain—Vinorelbine—breast cancer	0.000494	0.000942	CcSEcCtD
Latanoprost—Mediastinal disorder—Paclitaxel—breast cancer	0.000493	0.00094	CcSEcCtD
Latanoprost—Discomfort—Irinotecan—breast cancer	0.000491	0.000937	CcSEcCtD
Latanoprost—Discomfort—Mitoxantrone—breast cancer	0.000491	0.000937	CcSEcCtD
Latanoprost—Urinary tract infection—Capecitabine—breast cancer	0.000486	0.000927	CcSEcCtD
Latanoprost—Conjunctivitis—Capecitabine—breast cancer	0.000486	0.000927	CcSEcCtD
Latanoprost—Arthralgia—Gemcitabine—breast cancer	0.000484	0.000923	CcSEcCtD
Latanoprost—Chest pain—Gemcitabine—breast cancer	0.000484	0.000923	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000481	0.000917	CcSEcCtD
Latanoprost—Hepatic function abnormal—Doxorubicin—breast cancer	0.000479	0.000913	CcSEcCtD
Latanoprost—Discomfort—Gemcitabine—breast cancer	0.000479	0.000912	CcSEcCtD
Latanoprost—Pruritus—Tamoxifen—breast cancer	0.000478	0.000911	CcSEcCtD
Latanoprost—Oedema—Irinotecan—breast cancer	0.000477	0.000909	CcSEcCtD
Latanoprost—Oedema—Mitoxantrone—breast cancer	0.000477	0.000909	CcSEcCtD
Latanoprost—Erythema—Paclitaxel—breast cancer	0.000476	0.000908	CcSEcCtD
Latanoprost—Chest pain—Fluorouracil—breast cancer	0.000476	0.000908	CcSEcCtD
Latanoprost—Pain—Thiotepa—breast cancer	0.000472	0.0009	CcSEcCtD
Latanoprost—Discomfort—Fluorouracil—breast cancer	0.000471	0.000897	CcSEcCtD
Latanoprost—Pruritus—Melphalan—breast cancer	0.000468	0.000892	CcSEcCtD
Latanoprost—Nervous system disorder—Irinotecan—breast cancer	0.000467	0.000891	CcSEcCtD
Latanoprost—Eczema—Doxorubicin—breast cancer	0.000466	0.000888	CcSEcCtD
Latanoprost—Oedema—Gemcitabine—breast cancer	0.000464	0.000885	CcSEcCtD
Latanoprost—Eye pain—Doxorubicin—breast cancer	0.000463	0.000884	CcSEcCtD
Latanoprost—Skin disorder—Mitoxantrone—breast cancer	0.000463	0.000883	CcSEcCtD
Latanoprost—Back pain—Paclitaxel—breast cancer	0.000461	0.000878	CcSEcCtD
Latanoprost—Dizziness—Vinblastine—breast cancer	0.00046	0.000877	CcSEcCtD
Latanoprost—Pruritus—Goserelin—breast cancer	0.000457	0.00087	CcSEcCtD
Latanoprost—Oedema—Fluorouracil—breast cancer	0.000457	0.00087	CcSEcCtD
Latanoprost—Connective tissue disorder—Docetaxel—breast cancer	0.000456	0.000869	CcSEcCtD
Latanoprost—Nervous system disorder—Gemcitabine—breast cancer	0.000455	0.000868	CcSEcCtD
Latanoprost—Diplopia—Epirubicin—breast cancer	0.000452	0.000862	CcSEcCtD
Latanoprost—Skin disorder—Gemcitabine—breast cancer	0.000451	0.00086	CcSEcCtD
Latanoprost—Vision blurred—Paclitaxel—breast cancer	0.000449	0.000856	CcSEcCtD
Latanoprost—Nervous system disorder—Fluorouracil—breast cancer	0.000448	0.000854	CcSEcCtD
Latanoprost—Dizziness—Tamoxifen—breast cancer	0.000447	0.000852	CcSEcCtD
Latanoprost—Connective tissue disorder—Capecitabine—breast cancer	0.000441	0.000841	CcSEcCtD
Latanoprost—Headache—Vinblastine—breast cancer	0.000436	0.000831	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Methotrexate—breast cancer	0.000435	0.00083	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.000434	0.000828	CcSEcCtD
Latanoprost—Dizziness—Goserelin—breast cancer	0.000427	0.000814	CcSEcCtD
Latanoprost—Rash—Tamoxifen—breast cancer	0.000426	0.000812	CcSEcCtD
Latanoprost—Dermatitis—Tamoxifen—breast cancer	0.000426	0.000811	CcSEcCtD
Latanoprost—Dyspnoea—Irinotecan—breast cancer	0.000425	0.00081	CcSEcCtD
Latanoprost—Dyspnoea—Mitoxantrone—breast cancer	0.000425	0.00081	CcSEcCtD
Latanoprost—Headache—Tamoxifen—breast cancer	0.000423	0.000807	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000423	0.000806	CcSEcCtD
Latanoprost—Diplopia—Doxorubicin—breast cancer	0.000418	0.000798	CcSEcCtD
Latanoprost—Mediastinal disorder—Docetaxel—breast cancer	0.000418	0.000797	CcSEcCtD
Latanoprost—Asthma—Methotrexate—breast cancer	0.000418	0.000796	CcSEcCtD
Latanoprost—Rash—Melphalan—breast cancer	0.000417	0.000795	CcSEcCtD
Latanoprost—Dermatitis—Melphalan—breast cancer	0.000417	0.000794	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000416	0.000793	CcSEcCtD
Latanoprost—Dyspnoea—Gemcitabine—breast cancer	0.000414	0.000789	CcSEcCtD
Latanoprost—Pruritus—Vinorelbine—breast cancer	0.000409	0.00078	CcSEcCtD
Latanoprost—Pain—Irinotecan—breast cancer	0.000408	0.000777	CcSEcCtD
Latanoprost—Pain—Mitoxantrone—breast cancer	0.000408	0.000777	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Epirubicin—breast cancer	0.000407	0.000776	CcSEcCtD
Latanoprost—Dyspnoea—Fluorouracil—breast cancer	0.000407	0.000776	CcSEcCtD
Latanoprost—Rash—Goserelin—breast cancer	0.000407	0.000776	CcSEcCtD
Latanoprost—Dermatitis—Goserelin—breast cancer	0.000407	0.000775	CcSEcCtD
Latanoprost—Chest pain—Paclitaxel—breast cancer	0.000406	0.000773	CcSEcCtD
Latanoprost—Arthralgia—Paclitaxel—breast cancer	0.000406	0.000773	CcSEcCtD
Latanoprost—Mediastinal disorder—Capecitabine—breast cancer	0.000405	0.000772	CcSEcCtD
Latanoprost—Headache—Goserelin—breast cancer	0.000404	0.000771	CcSEcCtD
Latanoprost—Erythema—Docetaxel—breast cancer	0.000404	0.00077	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000403	0.000768	CcSEcCtD
Latanoprost—Discomfort—Paclitaxel—breast cancer	0.000401	0.000764	CcSEcCtD
Latanoprost—Pain—Gemcitabine—breast cancer	0.000397	0.000757	CcSEcCtD
Latanoprost—Erythema—Capecitabine—breast cancer	0.000391	0.000745	CcSEcCtD
Latanoprost—Asthma—Epirubicin—breast cancer	0.000391	0.000745	CcSEcCtD
Latanoprost—Back pain—Docetaxel—breast cancer	0.000391	0.000745	CcSEcCtD
Latanoprost—Pruritus—Thiotepa—breast cancer	0.000391	0.000744	CcSEcCtD
Latanoprost—Pain—Fluorouracil—breast cancer	0.00039	0.000744	CcSEcCtD
Latanoprost—Oedema—Paclitaxel—breast cancer	0.000389	0.000741	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Methotrexate—breast cancer	0.000388	0.00074	CcSEcCtD
Latanoprost—Dizziness—Vinorelbine—breast cancer	0.000382	0.000729	CcSEcCtD
Latanoprost—Nervous system disorder—Paclitaxel—breast cancer	0.000381	0.000727	CcSEcCtD
Latanoprost—Angina pectoris—Epirubicin—breast cancer	0.000381	0.000726	CcSEcCtD
Latanoprost—Back pain—Capecitabine—breast cancer	0.000378	0.000721	CcSEcCtD
Latanoprost—Skin disorder—Paclitaxel—breast cancer	0.000378	0.00072	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000377	0.000718	CcSEcCtD
Latanoprost—Bronchitis—Epirubicin—breast cancer	0.000376	0.000717	CcSEcCtD
Latanoprost—Vision blurred—Capecitabine—breast cancer	0.000368	0.000702	CcSEcCtD
Latanoprost—Dizziness—Thiotepa—breast cancer	0.000365	0.000696	CcSEcCtD
Latanoprost—Rash—Vinorelbine—breast cancer	0.000364	0.000695	CcSEcCtD
Latanoprost—Dermatitis—Vinorelbine—breast cancer	0.000364	0.000694	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Epirubicin—breast cancer	0.000363	0.000692	CcSEcCtD
Latanoprost—Headache—Vinorelbine—breast cancer	0.000362	0.00069	CcSEcCtD
Latanoprost—Conjunctivitis—Methotrexate—breast cancer	0.000362	0.00069	CcSEcCtD
Latanoprost—Asthma—Doxorubicin—breast cancer	0.000362	0.000689	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000354	0.000675	CcSEcCtD
Latanoprost—Angina pectoris—Doxorubicin—breast cancer	0.000352	0.000672	CcSEcCtD
Latanoprost—Rash—Thiotepa—breast cancer	0.000348	0.000663	CcSEcCtD
Latanoprost—Bronchitis—Doxorubicin—breast cancer	0.000348	0.000663	CcSEcCtD
Latanoprost—Dermatitis—Thiotepa—breast cancer	0.000348	0.000663	CcSEcCtD
Latanoprost—Dyspnoea—Paclitaxel—breast cancer	0.000347	0.000661	CcSEcCtD
Latanoprost—Headache—Thiotepa—breast cancer	0.000346	0.000659	CcSEcCtD
Latanoprost—Chest pain—Docetaxel—breast cancer	0.000344	0.000655	CcSEcCtD
Latanoprost—Arthralgia—Docetaxel—breast cancer	0.000344	0.000655	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000341	0.000651	CcSEcCtD
Latanoprost—Urinary tract infection—Epirubicin—breast cancer	0.000339	0.000646	CcSEcCtD
Latanoprost—Conjunctivitis—Epirubicin—breast cancer	0.000339	0.000646	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Doxorubicin—breast cancer	0.000336	0.000641	CcSEcCtD
Latanoprost—Arthralgia—Capecitabine—breast cancer	0.000333	0.000634	CcSEcCtD
Latanoprost—Chest pain—Capecitabine—breast cancer	0.000333	0.000634	CcSEcCtD
Latanoprost—Pain—Paclitaxel—breast cancer	0.000332	0.000634	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000331	0.00063	CcSEcCtD
Latanoprost—Oedema—Docetaxel—breast cancer	0.00033	0.000628	CcSEcCtD
Latanoprost—Discomfort—Capecitabine—breast cancer	0.000329	0.000627	CcSEcCtD
Latanoprost—Pruritus—Gemcitabine—breast cancer	0.000329	0.000626	CcSEcCtD
Latanoprost—Nervous system disorder—Docetaxel—breast cancer	0.000323	0.000616	CcSEcCtD
Latanoprost—Pruritus—Fluorouracil—breast cancer	0.000323	0.000616	CcSEcCtD
Latanoprost—Skin disorder—Docetaxel—breast cancer	0.00032	0.00061	CcSEcCtD
Latanoprost—Oedema—Capecitabine—breast cancer	0.000319	0.000608	CcSEcCtD
Latanoprost—Dizziness—Irinotecan—breast cancer	0.000315	0.000601	CcSEcCtD
Latanoprost—Urinary tract infection—Doxorubicin—breast cancer	0.000313	0.000597	CcSEcCtD
Latanoprost—Conjunctivitis—Doxorubicin—breast cancer	0.000313	0.000597	CcSEcCtD
Latanoprost—Nervous system disorder—Capecitabine—breast cancer	0.000313	0.000596	CcSEcCtD
Latanoprost—Skin disorder—Capecitabine—breast cancer	0.00031	0.000591	CcSEcCtD
Latanoprost—Connective tissue disorder—Epirubicin—breast cancer	0.000307	0.000586	CcSEcCtD
Latanoprost—Dizziness—Fluorouracil—breast cancer	0.000302	0.000576	CcSEcCtD
Latanoprost—Mediastinal disorder—Methotrexate—breast cancer	0.000301	0.000574	CcSEcCtD
Latanoprost—Rash—Irinotecan—breast cancer	0.000301	0.000573	CcSEcCtD
Latanoprost—Rash—Mitoxantrone—breast cancer	0.000301	0.000573	CcSEcCtD
Latanoprost—Dermatitis—Mitoxantrone—breast cancer	0.0003	0.000572	CcSEcCtD
Latanoprost—Dermatitis—Irinotecan—breast cancer	0.0003	0.000572	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Docetaxel—breast cancer	0.0003	0.000572	CcSEcCtD
Latanoprost—Headache—Irinotecan—breast cancer	0.000299	0.000569	CcSEcCtD
Latanoprost—Headache—Mitoxantrone—breast cancer	0.000299	0.000569	CcSEcCtD
Latanoprost—Dyspnoea—Docetaxel—breast cancer	0.000294	0.00056	CcSEcCtD
Latanoprost—Rash—Gemcitabine—breast cancer	0.000293	0.000558	CcSEcCtD
Latanoprost—Dermatitis—Gemcitabine—breast cancer	0.000293	0.000558	CcSEcCtD
Latanoprost—Erythema—Methotrexate—breast cancer	0.000291	0.000555	CcSEcCtD
Latanoprost—Headache—Gemcitabine—breast cancer	0.000291	0.000555	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000291	0.000554	CcSEcCtD
Latanoprost—Rash—Fluorouracil—breast cancer	0.000288	0.000549	CcSEcCtD
Latanoprost—Dermatitis—Fluorouracil—breast cancer	0.000288	0.000548	CcSEcCtD
Latanoprost—Headache—Fluorouracil—breast cancer	0.000286	0.000545	CcSEcCtD
Latanoprost—Connective tissue disorder—Doxorubicin—breast cancer	0.000284	0.000542	CcSEcCtD
Latanoprost—Dyspnoea—Capecitabine—breast cancer	0.000284	0.000542	CcSEcCtD
Latanoprost—Mediastinal disorder—Epirubicin—breast cancer	0.000282	0.000537	CcSEcCtD
Latanoprost—Pain—Docetaxel—breast cancer	0.000282	0.000537	CcSEcCtD
Latanoprost—Back pain—Methotrexate—breast cancer	0.000281	0.000537	CcSEcCtD
Latanoprost—Pruritus—Paclitaxel—breast cancer	0.000275	0.000524	CcSEcCtD
Latanoprost—Vision blurred—Methotrexate—breast cancer	0.000274	0.000523	CcSEcCtD
Latanoprost—Pain—Capecitabine—breast cancer	0.000273	0.00052	CcSEcCtD
Latanoprost—Erythema—Epirubicin—breast cancer	0.000272	0.000519	CcSEcCtD
Latanoprost—Back pain—Epirubicin—breast cancer	0.000263	0.000502	CcSEcCtD
Latanoprost—Mediastinal disorder—Doxorubicin—breast cancer	0.000261	0.000497	CcSEcCtD
Latanoprost—Dizziness—Paclitaxel—breast cancer	0.000257	0.00049	CcSEcCtD
Latanoprost—Vision blurred—Epirubicin—breast cancer	0.000257	0.000489	CcSEcCtD
Latanoprost—Erythema—Doxorubicin—breast cancer	0.000252	0.00048	CcSEcCtD
Latanoprost—Chest pain—Methotrexate—breast cancer	0.000248	0.000472	CcSEcCtD
Latanoprost—Arthralgia—Methotrexate—breast cancer	0.000248	0.000472	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000246	0.000469	CcSEcCtD
Latanoprost—Rash—Paclitaxel—breast cancer	0.000245	0.000467	CcSEcCtD
Latanoprost—Dermatitis—Paclitaxel—breast cancer	0.000245	0.000467	CcSEcCtD
Latanoprost—Discomfort—Methotrexate—breast cancer	0.000245	0.000467	CcSEcCtD
Latanoprost—Back pain—Doxorubicin—breast cancer	0.000244	0.000465	CcSEcCtD
Latanoprost—Headache—Paclitaxel—breast cancer	0.000244	0.000464	CcSEcCtD
Latanoprost—Vision blurred—Doxorubicin—breast cancer	0.000237	0.000453	CcSEcCtD
Latanoprost—Pruritus—Docetaxel—breast cancer	0.000233	0.000444	CcSEcCtD
Latanoprost—Nervous system disorder—Methotrexate—breast cancer	0.000233	0.000444	CcSEcCtD
Latanoprost—Chest pain—Epirubicin—breast cancer	0.000232	0.000442	CcSEcCtD
Latanoprost—Arthralgia—Epirubicin—breast cancer	0.000232	0.000442	CcSEcCtD
Latanoprost—Skin disorder—Methotrexate—breast cancer	0.000231	0.00044	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.00023	0.000439	CcSEcCtD
Latanoprost—Discomfort—Epirubicin—breast cancer	0.000229	0.000437	CcSEcCtD
Latanoprost—Pruritus—Capecitabine—breast cancer	0.000226	0.00043	CcSEcCtD
Latanoprost—Oedema—Epirubicin—breast cancer	0.000222	0.000424	CcSEcCtD
Latanoprost—Nervous system disorder—Epirubicin—breast cancer	0.000218	0.000416	CcSEcCtD
Latanoprost—Dizziness—Docetaxel—breast cancer	0.000218	0.000415	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000216	0.000412	CcSEcCtD
Latanoprost—Skin disorder—Epirubicin—breast cancer	0.000216	0.000412	CcSEcCtD
Latanoprost—Arthralgia—Doxorubicin—breast cancer	0.000215	0.000409	CcSEcCtD
Latanoprost—Chest pain—Doxorubicin—breast cancer	0.000215	0.000409	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000213	0.000406	CcSEcCtD
Latanoprost—Discomfort—Doxorubicin—breast cancer	0.000212	0.000404	CcSEcCtD
Latanoprost—Dyspnoea—Methotrexate—breast cancer	0.000212	0.000404	CcSEcCtD
Latanoprost—Dizziness—Capecitabine—breast cancer	0.000211	0.000402	CcSEcCtD
Latanoprost—Rash—Docetaxel—breast cancer	0.000208	0.000396	CcSEcCtD
Latanoprost—Dermatitis—Docetaxel—breast cancer	0.000208	0.000396	CcSEcCtD
Latanoprost—Headache—Docetaxel—breast cancer	0.000206	0.000394	CcSEcCtD
Latanoprost—Oedema—Doxorubicin—breast cancer	0.000206	0.000392	CcSEcCtD
Latanoprost—Pain—Methotrexate—breast cancer	0.000203	0.000387	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000202	0.000386	CcSEcCtD
Latanoprost—Nervous system disorder—Doxorubicin—breast cancer	0.000202	0.000384	CcSEcCtD
Latanoprost—Rash—Capecitabine—breast cancer	0.000201	0.000383	CcSEcCtD
Latanoprost—Dermatitis—Capecitabine—breast cancer	0.000201	0.000383	CcSEcCtD
Latanoprost—Headache—Capecitabine—breast cancer	0.0002	0.000381	CcSEcCtD
Latanoprost—Skin disorder—Doxorubicin—breast cancer	0.0002	0.000381	CcSEcCtD
Latanoprost—Dyspnoea—Epirubicin—breast cancer	0.000198	0.000378	CcSEcCtD
Latanoprost—Pain—Epirubicin—breast cancer	0.00019	0.000362	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000187	0.000357	CcSEcCtD
Latanoprost—Dyspnoea—Doxorubicin—breast cancer	0.000183	0.00035	CcSEcCtD
Latanoprost—Pain—Doxorubicin—breast cancer	0.000176	0.000335	CcSEcCtD
Latanoprost—Pruritus—Methotrexate—breast cancer	0.000168	0.00032	CcSEcCtD
Latanoprost—Pruritus—Epirubicin—breast cancer	0.000157	0.0003	CcSEcCtD
Latanoprost—Dizziness—Methotrexate—breast cancer	0.000157	0.000299	CcSEcCtD
Latanoprost—Rash—Methotrexate—breast cancer	0.00015	0.000285	CcSEcCtD
Latanoprost—Dermatitis—Methotrexate—breast cancer	0.00015	0.000285	CcSEcCtD
Latanoprost—Headache—Methotrexate—breast cancer	0.000149	0.000284	CcSEcCtD
Latanoprost—Dizziness—Epirubicin—breast cancer	0.000147	0.00028	CcSEcCtD
Latanoprost—Pruritus—Doxorubicin—breast cancer	0.000145	0.000277	CcSEcCtD
Latanoprost—SLC22A1—Metabolism—NDUFS3—breast cancer	0.000145	0.000555	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HEY1—breast cancer	0.000144	0.00055	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—DLL1—breast cancer	0.000141	0.00054	CbGpPWpGaD
Latanoprost—Rash—Epirubicin—breast cancer	0.00014	0.000267	CcSEcCtD
Latanoprost—Dermatitis—Epirubicin—breast cancer	0.00014	0.000267	CcSEcCtD
Latanoprost—Headache—Epirubicin—breast cancer	0.000139	0.000265	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	0.000139	0.000532	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HIST1H2BC—breast cancer	0.000138	0.00053	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HIST1H2BK—breast cancer	0.000138	0.00053	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GRB7—breast cancer	0.000137	0.000525	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PDE4D—breast cancer	0.000137	0.000525	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CSF2—breast cancer	0.000136	0.000523	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CHST9—breast cancer	0.000136	0.000522	CbGpPWpGaD
Latanoprost—Dizziness—Doxorubicin—breast cancer	0.000136	0.000259	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—TAB2—breast cancer	0.000135	0.000516	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—ITPR1—breast cancer	0.000134	0.000514	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CNR2—breast cancer	0.000133	0.000512	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CXCL8—breast cancer	0.000133	0.000511	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—MMP3—breast cancer	0.000133	0.00051	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	0.000133	0.000509	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—DKK1—breast cancer	0.00013	0.000499	CbGpPWpGaD
Latanoprost—Rash—Doxorubicin—breast cancer	0.00013	0.000247	CcSEcCtD
Latanoprost—Dermatitis—Doxorubicin—breast cancer	0.00013	0.000247	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—VEGFC—breast cancer	0.000129	0.000495	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—COX11—breast cancer	0.000129	0.000494	CbGpPWpGaD
Latanoprost—Headache—Doxorubicin—breast cancer	0.000129	0.000246	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—JAG2—breast cancer	0.000127	0.000488	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—BRAF—breast cancer	0.000126	0.000484	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000126	0.000481	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—WNT1—breast cancer	0.000126	0.000481	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PLA2G4A—breast cancer	0.000125	0.00048	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CSF2—breast cancer	0.000124	0.000474	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000123	0.000471	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOTCH4—breast cancer	0.000119	0.000456	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GZMB—breast cancer	0.000118	0.000453	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CDA—breast cancer	0.000118	0.000452	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SHMT1—breast cancer	0.000118	0.000452	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCL2—breast cancer	0.000115	0.00044	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AGTR2—breast cancer	0.000115	0.00044	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC2A5—breast cancer	0.000114	0.000435	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLCO1B1—breast cancer	0.000114	0.000435	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTHLH—breast cancer	0.000114	0.000435	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—BMP2—breast cancer	0.000114	0.000435	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EDNRB—breast cancer	0.00011	0.000421	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APRT—breast cancer	0.00011	0.00042	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—TFRC—breast cancer	0.00011	0.00042	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PGR—breast cancer	0.000109	0.000417	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—THBS1—breast cancer	0.000108	0.000415	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ALB—breast cancer	0.000107	0.000411	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—MDM2—breast cancer	0.000106	0.000406	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000106	0.000405	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—RAF1—breast cancer	0.000105	0.000404	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FLT1—breast cancer	0.000103	0.000396	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ESRRA—breast cancer	0.000103	0.000395	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ANGPTL4—breast cancer	0.000103	0.000395	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SQSTM1—breast cancer	0.000103	0.000394	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGF3—breast cancer	0.000103	0.000394	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CG—breast cancer	0.000102	0.000392	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—JAG1—breast cancer	0.000102	0.000389	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PARP1—breast cancer	0.000101	0.000388	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOTCH3—breast cancer	0.000101	0.000388	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000101	0.000386	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CALCA—breast cancer	9.99e-05	0.000383	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RPS6—breast cancer	9.87e-05	0.000378	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGF4—breast cancer	9.8e-05	0.000375	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GPI—breast cancer	9.78e-05	0.000375	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HADHB—breast cancer	9.78e-05	0.000375	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCR4—breast cancer	9.76e-05	0.000374	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCL12—breast cancer	9.76e-05	0.000374	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	9.73e-05	0.000373	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—RAF1—breast cancer	9.69e-05	0.000372	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—BRAF—breast cancer	9.68e-05	0.000371	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PAK1—breast cancer	9.58e-05	0.000367	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—ALB—breast cancer	9.45e-05	0.000362	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TCF7L2—breast cancer	9.41e-05	0.000361	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AKT2—breast cancer	9.37e-05	0.000359	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALDH1A1—breast cancer	9.33e-05	0.000357	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALDH7A1—breast cancer	9.33e-05	0.000357	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CG—breast cancer	9.3e-05	0.000356	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOTCH2—breast cancer	9.07e-05	0.000348	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HSP90AA1—breast cancer	9.07e-05	0.000348	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CD—breast cancer	9e-05	0.000345	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PHGDH—breast cancer	8.94e-05	0.000343	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—UMPS—breast cancer	8.94e-05	0.000343	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ADSL—breast cancer	8.94e-05	0.000343	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—FHL2—breast cancer	8.94e-05	0.000343	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NME1—breast cancer	8.94e-05	0.000343	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—NCOA1—breast cancer	8.89e-05	0.000341	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PRL—breast cancer	8.83e-05	0.000338	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AGTR1—breast cancer	8.83e-05	0.000338	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—BRIP1—breast cancer	8.77e-05	0.000336	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LDHB—breast cancer	8.77e-05	0.000336	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HPSE—breast cancer	8.77e-05	0.000336	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—STK11—breast cancer	8.7e-05	0.000333	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ADAM10—breast cancer	8.7e-05	0.000333	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—PLG—breast cancer	8.67e-05	0.000332	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PLG—breast cancer	8.6e-05	0.00033	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AKT2—breast cancer	8.51e-05	0.000326	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGF10—breast cancer	8.46e-05	0.000324	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HMMR—breast cancer	8.31e-05	0.000319	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCC1—breast cancer	8.31e-05	0.000319	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA3—breast cancer	8.31e-05	0.000319	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CD—breast cancer	8.17e-05	0.000313	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PDGFA—breast cancer	8.17e-05	0.000313	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—MDM2—breast cancer	8.11e-05	0.000311	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—RAF1—breast cancer	8.08e-05	0.00031	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPARGC1B—breast cancer	8.05e-05	0.000309	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TGFBR2—breast cancer	8.05e-05	0.000308	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—HMOX1—breast cancer	8e-05	0.000307	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ITPR1—breast cancer	7.92e-05	0.000304	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP3—breast cancer	7.87e-05	0.000302	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ERBB4—breast cancer	7.87e-05	0.000302	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—STAT5A—breast cancer	7.87e-05	0.000302	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CB—breast cancer	7.85e-05	0.000301	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCB1—breast cancer	7.68e-05	0.000294	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SMAD4—breast cancer	7.62e-05	0.000292	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA4—breast cancer	7.6e-05	0.000291	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CA9—breast cancer	7.6e-05	0.000291	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IGF1R—breast cancer	7.57e-05	0.00029	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CXCL8—breast cancer	7.54e-05	0.000289	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HES1—breast cancer	7.44e-05	0.000285	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA2—breast cancer	7.41e-05	0.000284	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GPX2—breast cancer	7.41e-05	0.000284	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NCOR1—breast cancer	7.4e-05	0.000283	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PLA2G4A—breast cancer	7.4e-05	0.000283	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GPX4—breast cancer	7.32e-05	0.00028	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SULT1A1—breast cancer	7.32e-05	0.00028	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CSF2—breast cancer	7.31e-05	0.00028	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGF1—breast cancer	7.31e-05	0.00028	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—RAF1—breast cancer	7.3e-05	0.00028	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NRG1—breast cancer	7.26e-05	0.000278	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—H2AFX—breast cancer	7.21e-05	0.000276	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—IL2—breast cancer	7.21e-05	0.000276	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—E2F1—breast cancer	7.16e-05	0.000274	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—IDH1—breast cancer	7.15e-05	0.000274	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA1—breast cancer	7.15e-05	0.000274	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CB—breast cancer	7.12e-05	0.000273	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NAT2—breast cancer	7.07e-05	0.000271	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SPP1—breast cancer	6.88e-05	0.000264	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CXCL8—breast cancer	6.85e-05	0.000262	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ERBB3—breast cancer	6.8e-05	0.000261	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGFR2—breast cancer	6.79e-05	0.00026	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL2—breast cancer	6.54e-05	0.000251	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TERT—breast cancer	6.52e-05	0.00025	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGFR1—breast cancer	6.33e-05	0.000243	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HIF1A—breast cancer	6.23e-05	0.000239	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MED12—breast cancer	6.2e-05	0.000238	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—DPYD—breast cancer	6.2e-05	0.000238	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALDOA—breast cancer	6.1e-05	0.000234	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LEP—breast cancer	6.09e-05	0.000233	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CAV1—breast cancer	6.03e-05	0.000231	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KDR—breast cancer	5.96e-05	0.000228	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NCOA3—breast cancer	5.92e-05	0.000227	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC2A2—breast cancer	5.88e-05	0.000225	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ESR1—breast cancer	5.81e-05	0.000223	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—HRAS—breast cancer	5.81e-05	0.000223	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CPT1A—breast cancer	5.76e-05	0.000221	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTR—breast cancer	5.76e-05	0.000221	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCG2—breast cancer	5.76e-05	0.000221	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FN1—breast cancer	5.74e-05	0.00022	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NFKBIA—breast cancer	5.67e-05	0.000217	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HPGDS—breast cancer	5.65e-05	0.000217	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOTCH1—breast cancer	5.62e-05	0.000215	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HBA1—breast cancer	5.62e-05	0.000215	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APC—breast cancer	5.49e-05	0.00021	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KIT—breast cancer	5.49e-05	0.00021	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CG—breast cancer	5.49e-05	0.00021	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ACHE—breast cancer	5.48e-05	0.00021	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTT1—breast cancer	5.48e-05	0.00021	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EGF—breast cancer	5.43e-05	0.000208	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—MAPK3—breast cancer	5.26e-05	0.000202	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP17A1—breast cancer	5.19e-05	0.000199	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—BRAF—breast cancer	5.16e-05	0.000198	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ENO1—breast cancer	5.14e-05	0.000197	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGS1—breast cancer	5.14e-05	0.000197	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2D6—breast cancer	5.04e-05	0.000193	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IGF1—breast cancer	5.03e-05	0.000193	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKT2—breast cancer	5.03e-05	0.000193	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EGFR—breast cancer	5e-05	0.000192	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NCOA2—breast cancer	4.94e-05	0.000189	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CD—breast cancer	4.83e-05	0.000185	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ALB—breast cancer	4.8e-05	0.000184	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—FASN—breast cancer	4.79e-05	0.000184	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CA—breast cancer	4.78e-05	0.000183	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SERPINE1—breast cancer	4.78e-05	0.000183	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—BCHE—breast cancer	4.77e-05	0.000183	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—KRAS—breast cancer	4.73e-05	0.000181	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC5A5—breast cancer	4.72e-05	0.000181	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOS3—breast cancer	4.56e-05	0.000175	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NQO1—breast cancer	4.56e-05	0.000175	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC2A1—breast cancer	4.56e-05	0.000175	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—HRAS—breast cancer	4.45e-05	0.00017	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP3A4—breast cancer	4.44e-05	0.00017	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP1B1—breast cancer	4.37e-05	0.000167	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—RAF1—breast cancer	4.34e-05	0.000166	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CA—breast cancer	4.34e-05	0.000166	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MDM2—breast cancer	4.33e-05	0.000166	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RAF1—breast cancer	4.31e-05	0.000165	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RELA—breast cancer	4.29e-05	0.000164	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HSP90AA1—breast cancer	4.28e-05	0.000164	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ERBB2—breast cancer	4.26e-05	0.000163	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MTOR—breast cancer	4.21e-05	0.000161	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CB—breast cancer	4.21e-05	0.000161	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NCOA1—breast cancer	4.17e-05	0.00016	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—STK11—breast cancer	4.11e-05	0.000157	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP19A1—breast cancer	4.11e-05	0.000157	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCL8—breast cancer	4.04e-05	0.000155	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—HRAS—breast cancer	4.02e-05	0.000154	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN1B—breast cancer	3.95e-05	0.000151	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AKT1—breast cancer	3.91e-05	0.00015	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CASP3—breast cancer	3.87e-05	0.000148	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL2—breast cancer	3.87e-05	0.000148	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6—breast cancer	3.85e-05	0.000147	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—COMT—breast cancer	3.82e-05	0.000146	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTP1—breast cancer	3.8e-05	0.000146	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCND1—breast cancer	3.77e-05	0.000144	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—JUN—breast cancer	3.76e-05	0.000144	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HMOX1—breast cancer	3.75e-05	0.000144	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ITPR1—breast cancer	3.74e-05	0.000143	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CTNNB1—breast cancer	3.73e-05	0.000143	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP9—breast cancer	3.66e-05	0.00014	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN1A—breast cancer	3.64e-05	0.00014	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTEN—breast cancer	3.64e-05	0.000139	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCB1—breast cancer	3.6e-05	0.000138	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK8—breast cancer	3.56e-05	0.000136	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AKT1—breast cancer	3.55e-05	0.000136	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TYMS—breast cancer	3.53e-05	0.000135	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PLA2G4A—breast cancer	3.49e-05	0.000134	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NCOR1—breast cancer	3.49e-05	0.000134	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTM1—breast cancer	3.49e-05	0.000134	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SRC—breast cancer	3.37e-05	0.000129	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GPX1—breast cancer	3.34e-05	0.000128	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP1A1—breast cancer	3.31e-05	0.000127	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VEGFA—breast cancer	3.28e-05	0.000126	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ERCC2—breast cancer	3.28e-05	0.000126	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—STAT3—breast cancer	3.25e-05	0.000125	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK3—breast cancer	3.11e-05	0.000119	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTHFR—breast cancer	3.09e-05	0.000118	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MYC—breast cancer	3.02e-05	0.000116	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TGFB1—breast cancer	3.01e-05	0.000116	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EGFR—breast cancer	2.96e-05	0.000113	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CAV1—breast cancer	2.85e-05	0.000109	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KRAS—breast cancer	2.79e-05	0.000107	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CG—breast cancer	2.59e-05	9.93e-05	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CA—breast cancer	2.57e-05	9.83e-05	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TP53—breast cancer	2.48e-05	9.51e-05	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HRAS—breast cancer	2.37e-05	9.1e-05	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CD—breast cancer	2.28e-05	8.73e-05	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6—breast cancer	2.27e-05	8.71e-05	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALB—breast cancer	2.25e-05	8.62e-05	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NOS3—breast cancer	2.15e-05	8.25e-05	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKT1—breast cancer	2.1e-05	8.03e-05	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CB—breast cancer	1.99e-05	7.61e-05	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGS2—breast cancer	1.97e-05	7.54e-05	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTEN—breast cancer	1.72e-05	6.58e-05	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CA—breast cancer	1.21e-05	4.64e-05	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AKT1—breast cancer	9.89e-06	3.79e-05	CbGpPWpGaD
